Dr. Reddy's Still Can't Duck Suit Over Generic Angiomax
By Joshua Alston ( March 13, 2013, 9:21 PM EDT) -- A New Jersey federal judge refused Wednesday to reconsider Dr. Reddy's Laboratories Ltd.'s bid for a quick escape from The Medicines Co.'s patent infringement suit over the generics maker's version of the anti-coagulant Angiomax....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.